CeQur, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced the ...

Swiss medtech CeQur has raised $100 million in a new series E funding round for what it called its “most ambitious phase of ...

CeQur announced today that it closed a $100 million Series E financing round to support its mealtime insulin delivery ...

CeQur raises $100 million in a Series E round to expand its insulin delivery technology and accelerate growth in diabetes ...

CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced two recent FDA clearances for CeQur Simplicity™: extended wear of up to seven ...

CeQur announced today that it picked up two recent FDA clearances for its Simplicity mealtime insulin patch pump system.

Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe was led ...

LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, ...

San Francisco-based SonoThera closed an oversubscribed $125 million Series B financing round, saying it will use the proceeds ...

Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe was led ...